Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
Participating in colorectal cancer screening cuts the risk of dying from the disease by 43%, according to a landmark Swedish study of over 376,000 people followed for up to 14 years. The screening involves a simple at-home stool test that checks for hidden blood. Researchers say the findings make a compelling case for boosting participation rates, since about a third of eligible people still skip the test.
A major Swedish study published in JAMA Network Open found that people who actually participated in colorectal cancer screening had a 43% lower risk of dying from the disease — a significantly stronger benefit than previously estimated. The research, led by scientists at Karolinska Institutet and Umeå University, tracked more than 376,000 people for up to 14 years through the Stockholm-Gotland screening program.
The screening itself is straightforward: participants receive a home kit, submit a stool sample, and the sample is tested for microscopic traces of blood. If blood is detected, a colonoscopy is offered. Sweden provides this screening free of charge to adults aged 60–74 every two years.
By the Numbers:
Why it matters: Colorectal cancer is one of the most common cancers globally, but it's highly treatable when caught early. This study shows that simply completing a free, easy at-home test can dramatically improve survival odds — making participation a potentially life-saving decision.
